Apoptosis inducer NGFI-B is degraded by the proteasome and stabilized by treatment with EGF

Biochemical and Biophysical Research Communications

Volumn 417, Issue 4, 2012, Pages 1292-1297

  Strøm, Bjørn O ^a   Paulsen, Ragnhild E ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

EGF; NGFI B; Proteasome

Indexed keywords

AMINO ACID; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CELL NUCLEUS RECEPTOR; CYCLOHEXIMIDE; EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; NUCLEAR RECEPTOR NUR77; PROTEASOME;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; GENETIC TRANSFECTION; MUTATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; WILD TYPE;

ANIMALS; APOPTOSIS; CELL LINE; CERCOPITHECUS AETHIOPS; EPIDERMAL GROWTH FACTOR; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTATION; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STABILITY; PROTEOLYSIS;

EID: 84856285877     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.132     Document Type: Article

References (34)

1. Lee S.-O., Li X., Khan S., Safe S. Targeting NR4A1 (TR3) in cancer cells and tumors. Expert Opin. Ther. Targets 2011, 15:195-206.
2. Maruyama K., Tsukada T., Ohkura N., Bandoh S., Hosono T., Yamaguchi K. The NGFI-B subfamily of the nuclear receptor superfamily (review). Int. J. Oncol. 1998, 12:1237-1243.
3. Maxwell M.A., Muscat G.E. The NR4A subgroup: immediate early response genes with pleiotropic physiological roles. Nucl. Recept. Signal. 2006, 4:e002.
4. Kolluri S.K., Zhu X., Zhou X., Lin B., Chen Y., Sun K., Tian X., Town J., Cao X., Lin F., Zhai D., Kitada S., Luciano F., O'Donnell E., Cao Y., He F., Lin J., Reed J.C., Satterthwait A.C., Zhang X.-k. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer. Cancer Cell 2008, 14:285-298.
5. Cuzick J., DeCensi A., Arun B., Brown P.H., Castiglione M., Dunn B., Forbes J.F., Glaus A., Howell A., von Minckwitz G., Vogel V., Zwierzina H. Preventive therapy for breast cancer: a consensus statement. Lancet Oncol. 2011, 12:496-503.
6. Yang H., Bushue N., Bu P., Yvonne Wan Y.-J. Induction and intracellular localization of Nur77 dictate fenretinide-induced apoptosis of human liver cancer cells. Biochem. Pharmacol. 2010, 79:948-954.
7. Yang H., Nie Y., Li Y., Wan Y.-J.Y. ERK1/2 deactivation enhances cytoplasmic Nur77 expression level and improves the apoptotic effect of fenretinide in human liver cancer cells. Biochem. Pharmacol. 2011, 81:910-916.
8. Zhang X.-k. Targeting Nur77 translocation. Expert Opin. Ther. Targets 2006, 11:69-79.
9. Fahrner T.J., Carroll S.L., Milbrandt J. The NGFI-B protein, an inducible member of the thyroid/steroid receptor family, is rapidly modified posttranslationally. Mol. Cell Biol. 1990, 10:6454-6459.
10. Ryseck R.P., Macdonald-Bravo H., Mattei M.G., Ruppert S., Bravo R. Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J. 1989, 8:3327-3335.
11. Bochtler M., Ditzel L., Groll M., Hartmann C., Huber R. The proteasome. Annu. Rev. Biophys. Biomol. Struct. 1999, 28:295-317.
12. Ramakrishna S., Suresh B., Lim K.-H., Cha B.-H., Lee S.-H., Kim K.-S., Baek K.-H. PEST motif sequence regulating human NANOG for proteasomal degradation. Stem Cells Dev. 2011, 20:1511-1519.
13. Rechsteiner M., Rogers S.W. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 1996, 21:267-271.
14. Alarid E.T. Lives and times of nuclear receptors. Mol. Endocrinol. 2006, 20:1972-1981.
15. Meyer R.D., Srinivasan S., Singh A.J., Mahoney J.E., Gharahassanlou K.R., Rahimi N. PEST motif serine and tyrosine phosphorylation controls vascular endothelial growth factor receptor 2 stability and downregulation. Mol. Cell. Biol. 2011, 31:2010-2025.
16. Wingate A.D., Arthur J.S. Post-translational control of Nur77. Biochem. Soc. Trans. 2006, 34:1107-1109.
17. Slagsvold H.H., Østvold A.-C., Fallgren å.B., Paulsen R.E. Nuclear receptor and apoptosis initiator NGFI-B is a substrate for kinase ERK2. Biochem. Biophys. Res. Commun. 2002, 291:1146-1150.
18. Jacobs C.M., Boldingh K.A., Slagsvold H.H., Thoresen G.H., Paulsen R.E. ERK2 prohibits apoptosis-induced subcellular translocation of orphan nuclear receptor NGFI-B/TR3. J. Biol. Chem. 2004, 279:50097-50101.
19. Wang A., Rud J., Olson C.M., Anguita J., Osborne B.A. Phosphorylation of Nur77 by the MEK-ERK-RSK cascade induces mitochondrial translocation and apoptosis in T cells. J. Immunol. 2009, 183:3268-3277.
20. Paulsen R.E., Weaver C.A., Fahrner T.J., Milbrandt J. Domains regulating transcriptional activity of the inducible orphan receptor NGFI-B. J. Biol. Chem. 1992, 267:16491-16496.
21. McKeehan W., Hardesty B. The mechanism of cycloheximide inhibition of protein synthesis in rabbit reticulocytes. Biochem. Biophys. Res. Commun. 1969, 36:625-630.
22. Marshall G.M., Liu P.Y., Gherardi S., Scarlett C.J., Bedalov A., Xu N., Iraci N., Valli E., Ling D., Thomas W., van Bekkum M., Sekyere E., Jankowski K., Trahair T., MacKenzie K.L., Haber M., Norris M.D., Biankin A.V., Perini G., Liu T. SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability. PLoS Genet. 2011, 7:e1002135.
23. Watanabe H., Tanaka Y., Shimazu Y., Sugahara F., Kuwayama M., Hiramatsu A., Kiyotani K., Yoshida T., Sakaguchi T. Cell-specific inhibition of paramyxovirus maturation by proteasome inhibitors. Microbiol. Immunol. 2005, 49:835-844.
24. Hazel T.G., Misra R., Davis I.J., Greenberg M.E., Lau L.F. Nur77 is differentially modified in PC12 cells upon membrane depolarization and growth factor treatment. Mol. Cell. Biol. 1991, 11:3239-3246.
25. Peleg S., Nguyen C.V. The importance of nuclear import in protection of the vitamin D receptor from polyubiquitination and proteasome-mediated degradation. J. Cell. Biochem. 2010, 110:926-934.
26. Acquaviva C., Brockly F., Ferrara P., Bossis G., Salvat C., Jariel-Encontre I., Piechaczyk M. Identification of a C-terminal tripeptide motif involved in the control of rapid proteasomal degradation of c-Fos proto-oncoprotein during the G(0)-to-S phase transition. Oncogene 2001, 20:7563-7572.
27. Jo A.Y., Kim M.-Y., Lee H.-S., Rhee Y.-H., Lee J.-E., Baek K.-H., Park C.-H., Koh H.-C., Shin I., Lee Y.-S., Lee S.-H. Generation of dopamine neurons with improved cell survival and phenotype maintenance using a degradation-resistant Nurr1 mutant. Stem Cells 2009, 27:2238-2246.
28. Park S., Song J., Joe C.O., Shin I. Akt stabilizes estrogen receptor α with the concomitant reduction in its transcriptional activity. Cell. Signal. 2008, 20:1368-1374.
29. He X., Zheng Z., Song T., Wei C., Ma H., Ma Q., Zhang Y., Xu Y., Shi W., Ye Q., Zhong H. c-Abl regulates estrogen receptor [alpha] transcription activity through its stabilization by phosphorylation. Oncogene 2010, 29:2238-2251.
30. Nguyen T., Sherratt P.J., Huang H.-C., Yang C.S., Pickett C.B. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. J. Biol. Chem. 2003, 278:4536-4541.
31. Kang S.-A., Na H., Kang H.-J., Kim S.-H., Lee M.-H., Lee M.-O. Regulation of Nur77 protein turnover through acetylation and deacetylation induced by p300 and HDAC1. Biochem. Pharmacol. 2010, 80:867-873.
32. Chen H.Z., Li L., Wang W.J., Du X.D., Wen Q., He J.P., Zhao B.X., Li G.D., Zhou W., Xia Y., Yang Q.Y., Hew C.L., Liou Y.C., Wu Q. Prolyl isomerase Pin1 stabilizes and activates orphan nuclear receptor TR3 to promote mitogenesis. Oncogene 2011, 10.1038/onc.2011.463.
33. Rivett A.J., Knecht E. Proteasome location. Curr. Biol. 1993, 3:127-129.
34. Jacobs C.M., Paulsen R.E. Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B. Biochem. Biophys. Res. Commun. 2005, 336:646-652.